Zobrazeno 1 - 10
of 18
pro vyhledávání: '"François Hyafil"'
Autor:
Jean-Marie Bernassau, François Hyafil
Publikováno v:
Journal of Magnetic Resonance (1969). 40:245-258
The effect of the choice of the τ sequence in the inversion-recovery experiment is examined. The uncertainty in the value of T1 can be related to a function F of T1, the pulse interval delay, and the τi's. Minimization of the function for a range o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::195fad3462c4a4da5cbb2497f24a443e
https://doi.org/10.1016/0022-2364(80)90248-6
https://doi.org/10.1016/0022-2364(80)90248-6
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Protein Structure. 446:472-478
Hemoglobin St Louis β28 (B10) LeuaGln is a new mutant which occurs as a natural valency hybrid (α2β2+), or hemoglobin M (Cohen-Solal, M., Seligmann, M., Thillet, J. and Rosa, J. (1973) FEBS Lett. 33, 37–41). The electron paramagnetic resonance (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1b640e91e644c40db27ca33485b4ef5
https://doi.org/10.1016/0005-2795(76)90013-1
https://doi.org/10.1016/0005-2795(76)90013-1
Autor:
Pierre Reculard, Philippe Adamowicz, François Hyafil, Georges Lucas, Roger Vinas, Paul Prunet, Gisèle Chabanier
Publikováno v:
Vaccine. 2(3)
As first generation hepatitis B vaccines are derived from human plasma, detailed information is required concerning the elimination of hepatitis B virus and other potential transmissible infectious agents during vaccine preparation. To demonstrate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55c3070cdb35aff1e529bb4e17500f9c
https://pubmed.ncbi.nlm.nih.gov/6241769
https://pubmed.ncbi.nlm.nih.gov/6241769
Autor:
Alexis Denis, Olivier Lequin, Amélie Guihot, Pascal Grondin, Philippe Karoyan, Luis Gómez-Morales, Charles-Edouard Luyt, Vincent Vieillard, Estelle Odile
Publikováno v:
Communications Biology
Communications Biology, 2021, 4 (1), pp.197. ⟨10.1038/s42003-021-01736-8⟩
Communications Biology, Nature Publishing Group, 2021, 4, ⟨10.1038/s42003-021-01736-8⟩
Communications Biology, Nature Publishing Group, 2021, 4 (1), ⟨10.1038/s42003-021-01736-8⟩
Communications Biology, Vol 4, Iss 1, Pp 1-9 (2021)
Communications Biology, 2021, 4 (1), pp.197. ⟨10.1038/s42003-021-01736-8⟩
Communications Biology, Nature Publishing Group, 2021, 4, ⟨10.1038/s42003-021-01736-8⟩
Communications Biology, Nature Publishing Group, 2021, 4 (1), ⟨10.1038/s42003-021-01736-8⟩
Communications Biology, Vol 4, Iss 1, Pp 1-9 (2021)
In light of the recent accumulated knowledge on SARS-CoV-2 and its mode of human cells invasion, the binding of viral spike glycoprotein to human Angiotensin Converting Enzyme 2 (hACE2) receptor plays a central role in cell entry. We designed a serie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63f663d504d8ddf9493bf5978b00772b
https://hal.sorbonne-universite.fr/hal-03141346/file/s42003-021-01736-8.pdf
https://hal.sorbonne-universite.fr/hal-03141346/file/s42003-021-01736-8.pdf
Autor:
Denèfle, Thomas, Pramil, Elodie, Gómez-Morales, Luis, Levasseur, Mikail, Lardé, Eva, Newton, Clara, Herry, Kenny, Herbi, Linda, Lamotte, Yann, Odile, Estelle, Ancellin, Nicolas, Grondin, Pascal, Martinez-Torres, Ana-Carolina, Viviani, Fabrice, Merle-Béral, Hélène, Lequin, Olivier, Susin, Santos, Karoyan, Philippe
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (17), pp.7656-7668. ⟨10.1021/acs.jmedchem.9b00024⟩
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (17), pp.7656-7668. ⟨10.1021/acs.jmedchem.9b00024⟩
International audience; In order to optimize the potency of the first serum-stable peptide agonist of CD47 (PKHB1) in triggering regulated cell death of cancer cells, we designed a maturation process aimed to mimic the trimeric structure of the throm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::377597376618d209fd42ff4d72a8f720
https://hal.sorbonne-universite.fr/hal-02367977/document
https://hal.sorbonne-universite.fr/hal-02367977/document
Autor:
Carole Le Bachelier, Dimitri Schlemmer, Jean-François Benoist, Jean Bastin, Céline Tomkiewicz-Raulet, Yann Lamotte, Sophie Mouillet-Richard, Olivier Mirguet, Pascal Grondin, Fatima-Zohra Boufroura, Fatima Djouadi
Publikováno v:
Human Molecular Genetics
Human Molecular Genetics, Oxford University Press (OUP), 2018, 27 (19), pp.3417-3433. ⟨10.1093/hmg/ddy254⟩
Human Molecular Genetics, 2018, 27 (19), pp.3417-3433. ⟨10.1093/hmg/ddy254⟩
Human Molecular Genetics, Oxford University Press (OUP), 2018, 27 (19), pp.3417-3433. ⟨10.1093/hmg/ddy254⟩
Human Molecular Genetics, 2018, 27 (19), pp.3417-3433. ⟨10.1093/hmg/ddy254⟩
International audience; Carnitine palmitoyl transferase 2 (CPT2) deficiency is one of the most common inherited fatty acid oxidation (FAO) defects and represents a prototypical mitochondrial metabolic myopathy. Recent studies have suggested a pivotal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b494830374ae90f40221eafc1ff3af40
https://www.hal.inserm.fr/inserm-02894027/document
https://www.hal.inserm.fr/inserm-02894027/document
Autor:
Pierre Sujobert, Laury Poulain, Etienne Paubelle, Florence Zylbersztejn, Adrien Grenier, Mireille Lambert, Elizabeth C. Townsend, Jean-Marie Brusq, Edwige Nicodeme, Justine Decrooqc, Ina Nepstad, Alexa S. Green, Johanna Mondesir, Marie-Anne Hospital, Nathalie Jacque, Alexandra Christodoulou, Tiffany A. Desouza, Olivier Hermine, Marc Foretz, Benoit Viollet, Catherine Lacombe, Patrick Mayeux, David M. Weinstock, Ivan C. Moura, Didier Bouscary, Jerome Tamburini
Publikováno v:
Cell Reports, Vol 11, Iss 9, Pp 1446-1457 (2015)
Cell Reports
Cell Reports, 2015, Epub ahead of print. ⟨10.1016/j.celrep.2015.04.063⟩
Cell Reports, Elsevier (Cell Press), 2015, Epub ahead of print. 〈10.1016/j.celrep.2015.04.063〉
Cell Reports, Elsevier Inc, 2015, Epub ahead of print. ⟨10.1016/j.celrep.2015.04.063⟩
Cell Reports
Cell Reports, 2015, Epub ahead of print. ⟨10.1016/j.celrep.2015.04.063⟩
Cell Reports, Elsevier (Cell Press), 2015, Epub ahead of print. 〈10.1016/j.celrep.2015.04.063〉
Cell Reports, Elsevier Inc, 2015, Epub ahead of print. ⟨10.1016/j.celrep.2015.04.063⟩
SummaryAMPK is a master regulator of cellular metabolism that exerts either oncogenic or tumor suppressor activity depending on context. Here, we report that the specific AMPK agonist GSK621 selectively kills acute myeloid leukemia (AML) cells but sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::924dd5db86ae4a82fa7d10ea18adb9e8
https://doi.org/10.1016/j.celrep.2015.04.063
https://doi.org/10.1016/j.celrep.2015.04.063
Autor:
Combrisson, Hélène, Durand, Valérie, Joubert, Christophe, MALPAUX, Benoit, Maximilien, Rémi, Montagutelli, Xavier, Peyclit, Isabelle, Picavet, Sophie, Ramette, Jacques, ROCHET, Violaine, Sandra, Olivier, Schmid, Anne-Françoise
Publikováno v:
STAL Sciences et Techniques de l'Animal de Laboratoire
STAL Sciences et Techniques de l'Animal de Laboratoire, 2016, 42 (4ème trimestre 2016), pp.26-28
STAL Sciences et Techniques de l'Animal de Laboratoire, 2016, 42 (4ème trimestre 2016), pp.26-28
Guide de rédaction du résumé non technique des demandes d'autorisation de Projet utilisant des animaux à des fins scientifiques : un concept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::75dfdf54cfa4dde3a3f6622f87e0dc25
https://hal.archives-ouvertes.fr/hal-01607613
https://hal.archives-ouvertes.fr/hal-01607613
Autor:
Galhaut M; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Lundberg U; VALNEVA Austria GmbH, Vienna, Austria., Marlin R; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Schlegl R; VALNEVA Austria GmbH, Vienna, Austria., Seidel S; VALNEVA Austria GmbH, Vienna, Austria., Bartuschka U; VALNEVA Austria GmbH, Vienna, Austria., Heindl-Wruss J; VALNEVA Austria GmbH, Vienna, Austria., Relouzat F; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Langlois S; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Dereuddre-Bosquet N; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Morin J; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Galpin-Lebreau M; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Gallouët AS; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Gros W; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Naninck T; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Pascal Q; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Chapon C; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Mouchain K; ONCODESIGN SERVICES, François Hyafil Research Center, Villebon-sur-Yvette, France., Fichet G; ONCODESIGN SERVICES, François Hyafil Research Center, Villebon-sur-Yvette, France., Lemaitre J; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Cavarelli M; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Contreras V; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Legrand N; ONCODESIGN SERVICES, François Hyafil Research Center, Villebon-sur-Yvette, France., Meinke A; VALNEVA Austria GmbH, Vienna, Austria. Andreas.MEINKE@valneva.com., Le Grand R; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France. roger.le-grand@cea.fr.
Publikováno v:
Communications medicine [Commun Med (Lond)] 2024 Apr 03; Vol. 4 (1), pp. 62. Date of Electronic Publication: 2024 Apr 03.
Autor:
Wang S; Regularoty and Medical Affairs Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Xu L; Project Management Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Mu T; Innovative Discovery Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Qin M; Project Management Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Zhao P; Test Development Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Xie L; Innovative Discovery Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Du L; China Office, Voisin Consulting Life Sciences, Shanghai, China., Wu Y; Test Development Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Legrand N; In Vivo Sciences Department, Oncodesign, Centre François Hyafil, Villebon-sur-Yvette, France., Mouchain K; DMPK & Bioanalytical Sciences Department, Oncodesign, Centre François Hyafil, Villebon-sur-Yvette, France., Fichet G; In Vitro Sciences Department, Oncodesign, Centre François Hyafil, Villebon-sur-Yvette, France., Liu Y; Project Management Department, Wuhan BravoVax Co., Ltd., Wuhan, China.; State Key Laboratory of Biocatalysts and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, China., Yin W; Project Management Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Zhao J; Test Development Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Ji M; Regularoty and Medical Affairs Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Gong B; Regularoty and Medical Affairs Department, Wuhan BravoVax Co., Ltd., Wuhan, China., Klein M; Executive Office, Wuhan BravoVax Co., Ltd., Wuhan, China.; Executive Office, Shanghai BravoBio Co., Ltd., Shanghai, China., Wu K; Executive Office, Wuhan BravoVax Co., Ltd., Wuhan, China.; Executive Office, Shanghai BravoBio Co., Ltd., Shanghai, China.
Publikováno v:
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 Nov 03; Vol. 12, pp. 979641. Date of Electronic Publication: 2022 Nov 03 (Print Publication: 2022).